Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease	Active, not recruiting	Phase 2	2025-08-08		NCT01461837

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ann & Robert H Lurie Children's Hospital of Chicago	76
Medical College of Wisconsin	201
Miltenyi Biomedicine GmbH	22
New York Medical College	28
Tufts Medical Center	50
UCSF Benioff Children's Hospital Oakland	4
University of California, Los Angeles	355
University of California, San Francisco	637
Washington University School of Medicine	475

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's Hospital and Research Center Oakland	Oakland	United States	1
Lurie Children's Hospital	Chicago	United States	1
Medical College of Wisconsin/Children's Hospital of Wisconsin	Milwaukee	United States	6
New York Medical College	Valhalla	United States	71
University of California Los Angeles (UCLA)	Los Angeles	United States	11
Washington University/St. Louis Children's Hospital	St Louis	United States	2